Ischemic and viable myocardium in patients with Non–Q-Wave or Q-Wave myocardial infarction and left ventricular dysfunction A clinical study using positron emission tomography, echocardiography, and electrocardiography by Yang, Hua et al.
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OBJECTIVES We investigated whether patients with non–Q-wave myocardial infarction (NQMI) have
more ischemic viable myocardium (IVM) than patients with Q-wave myocardial infarction
(QMI).
BACKGROUND Non–Q-wave myocardial infarction is associated with higher incidences of cardiac events than
QMI, suggesting more myocardium at risk in NQMI.
METHODS To identify myocardial ischemia, hibernation, and scar, the resting and stress 82rubidium
perfusion and F-18 fluorodeoxyglucose metabolic positron emission tomographic imaging
(PET) was performed in 64 consecutive patients with NQMI (n  21) or QMI (n  43).
Echocardiography was performed for assessment of left ventricular function and wall motion
index (WMI). The relationships between PET, echocardiographic, and electrocardiographic
findings were analyzed.
RESULTS There were no significant differences in left ventricular ejection fraction (LVEF) between
NQMI and QMI groups (28  10% vs. 25  11%, p  0.05). Ischemic and viable
myocardium was more common in NQMI than in QMI (91% vs. 61%, p  0.05). The total
amount of IVM was significantly higher in NQMI than in QMI (6.5  5.2 vs. 2.9  2.8
segments, p  0.001). Neither the number of Q waves, residual ST-segment depression of
0.5 mm or elevation of 1 mm, nor LVEF and WMI were significant predictors for IVM.
Wall motion index correlated with scar segments (r  0.54, p  0.001) and LVEF (r 
0.67, p  0.001).
CONCLUSIONS Ischemic and viable myocardium is common in patients with NQMI and left ventricular
dysfunction, suggesting that aggressive approaches should be taken to salvage the myocar-
dium at risk in such patients. (J Am Coll Cardiol 2004;43:592–8) © 2004 by the American
College of Cardiology FoundationQ
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iraditionally, myocardial infarction (MI) may be catego-
ized as Q-wave MI (QMI) or non–Q-wave MI (NQMI)
ased on the electrocardiogram (ECG). Although QMI is
requently associated with transmural MI, and NQMI with
ontransmurality, pathological studies have demonstrated
hat the presence of Q waves on the ECG does not reliably
ifferentiate transmural from nontransmural scar (1,2).
here are both pathophysiological and clinical differences
etween NQMI and QMI (2,3). Q-wave MI is almost
lways associated with ST elevation, and thrombolytic
herapy decreases mortality. Non–Q-wave MI often pre-
ents with non–ST-elevation MI, and thrombolysis is not
eneficial (4,5) or even harmful (6,7).
Although NQMI may have infarct size smaller than
From the Departments of *Cardiology and †Nuclear Medicine, Cleveland Clinic
oundation, Cleveland, Ohio. This study was partially presented at the 2001
cientific Sessions of the American Heart Association, November 11 to 14, 2001,
naheim, California.
Manuscript received May 21, 2003; revised manuscript received July 17, 2003,(ccepted July 28, 2003.MI as measured by peak creatine kinase levels (3,8), it is
ften associated with higher incidence of late cardiac events
ncluding recurrent ischemia, angina, or MI than QMI
9,10). Despite a favorable early prognosis, a long-term
urvival in patients with NQMI is similar to that in patients
ith QMI (11). Postinfarction ischemia, angina, and rein-
arction presage increased late mortality in patients recov-
ring from NQMI (12–14), suggesting that patients with
QMI might have more myocardium at risk (stress-
nduced ischemia and/or hibernating myocardium) than
ndividuals with QMI. These clinical characteristics of
QMI have led to a speculation that an invasive strategy
ith early revascularization would improve outcome in
atients with NQMI. However, two large clinical trials had
ontradictory results (15,16). The objective of this study was
o investigate whether patients with NQMI had more
tress-induced ischemia and/or hibernating myocardium
dentified by positron emission tomography perfusion
PET) with metabolic imaging than those with QMI. The
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February 18, 2004:592–8 Viable Myocardium in Non–Q-Wave and Q-Wave MItudy also evaluated whether resting electrocardiography
nd echocardiography can be used to predict myocardium at
isk in patients with NQMI or QMI and left ventricular
ysfunction. In this study, we specifically investigated pa-
ients with left ventricular dysfunction after NQMI or QMI
ecause left ventricular dysfunction is strongly associated
ith prognosis, and left ventricular function may signifi-
antly improve after revascularization of ischemic viable
yocardium (IVM) (17–19).
ETHODS
atient population. Seventy-three consecutive patients
ith clinical history of MI (more than one month after
cute MI) were studied. A 12-lead ECG, echocardiography,
nd PET were performed as clinically indicated. Mean left
entricular ejection fraction (LVEF) was 26  11% by
chocardiography. Patients were divided into NQMI and
MI groups according to the presence or absence of the
athological Q-wave in at least two contiguous leads on a
esting 12-lead ECG. Q-wave MI was defined by two
riteria: 1) documented MI by clinical history and cardiac
nzymes, 2) pathological Q waves were present in two
ontiguous leads in a 12-lead ECG. Non–Q-wave MI was
efined by the following criteria: 1) documented MI by
linical history and/or cardiac enzymes, 2) no Q-wave in a
2-lead ECG. There were 21 patients meeting NQMI
riteria and 43 patients meeting QMI criteria. Nine patients
ith nondiagnostic ECG (seven patients with left bundle
ranch block and two patients with pacing rhythm) were
xcluded from the study because we were unable to deter-
ine whether the patients had Q-wave or non–Q-wave MI.
linical characteristics of these 64 patients are listed in
able 1.
CG. Patients were divided into the QMI or NQMI
roups depending on the presence (QMI) or absence
NQMI) of pathological Q waves on 12-lead resting ECG.
athological Q-wave was considered present if Q-wave was
qual to, or greater than, 0.04 seconds in duration and
eeper than one-fourth of the following R wave in voltage.
our major infarct regions (septal, anterior, lateral, and
nferior) were defined in this study according to the location
f Q waves. Septal infarction was defined as the presence of
athologic Q waves in precordial leads V1 to V3. Anterior
Abbreviations and Acronyms
IVM  ischemic viable myocardium
LVEF  left ventricular ejection fraction
MI  myocardial infarction
NQMI  non–Q-wave myocardial infarction
PET  positron emission tomography
QMI  Q-wave myocardial infarction
WMI  wall motion score index
18FDG  fluorodeoxyglucose-18
82Rb  rubidium-82nfarction was defined as the preservation of the R-wave in s1 with pathological Q-wave in at least two leads from V2
o V5. If Q waves were present in both septal V1 to V3 and
nterior leads V4 to V5, infarction was considered as two
egions (septal plus anterior regional infarction). Lateral
nfarction was defined by pathologic Q waves in at least two
f leads I, aVL, or V6. Inferior infarction was identified by
he presence of pathological Q waves in at least two of leads
I, III, or aVF. A multiregional infarction determined by
CG was defined when more than one region was involved.
he number of ECG leads with ST-segment elevation of
1 mm or ST depression of 0.5 mm and the sum of
T-segment elevation of 1 mm or ST depression of 0.5
m was also analyzed.
ET study. Positron emission tomography was performed
sing a Posicam scanner (Positron Corp., Houston, Texas).
fter transmission images of the thorax were obtained
minimum 60 M counts), 60 mCi of rubidium-82 (82Rb)
as given intravenously, and 4-min resting perfusion images
ere obtained. Following isotope decay, 0.56 ml/kg of
ipyridamole was infused intravenously over a 4-min inter-
al. A second dose of 60 mCi was given, and 82Rb stress
erfusion images were acquired for 4 min. Positron emission
omography metabolic imaging was performed following
ral glucose loading (25 to 50 g) 40 min after 3 to 10 mCi
f fluorodeoxyglucose-18 (18FDG) was given intravenously.
wenty-one transaxial images were reconstructed and cor-
ected for soft tissue attenuation using the transmission
mages. Images were resliced into standard horizontal long-
xis, vertical long-axis, and short-axis views. The resliced
ET images were displayed on a VAX workstation (Digital
quipment, Hewlett-Packard, Palo Alto, California), uti-
izing 5%, 10%, or continuous display color bars. A perfu-
ion defect was defined as a relative tracer concentration of
70% of maximal myocardial activity. Reversible perfusion
efect (ischemia) was determined as a perfusion defect
etected on 82Rb dipyridamole-stress perfusion images with
o perfusion defect detected on resting images in the same
able 1. Clinical Characteristics in the Patients With NQMI
r QMI
NQMI (n  21) QMI (n  43)
ge (yrs) 64.0  8.4 63.5  10.3
ale 14 (66.7%) 32 (74.4%)
R (beat/min) 79  11.4 80  19.8
ABG 9 (42.9%) 21 (48.8%)
AD vessels 2.2  0.8 2.6  0.6*
VDd (cm) 6.1  0.5 6.4  1.2
VDs (cm) 4.7  0.8 5.2  1.3
VEF (%) 28  10 25  11
R severity 1.4  1.2 1.5  1.0
MI 1.9  0.6 2.2  0.5
p  0.05.
CABG coronary artery bypass grafting; CAD vessels the number of epicardial
essels with 50% stenosis; HR  heart rate; LVDd  left ventricular end-diastolic
imension; LVDs  left ventricular end-systolic dimension; LVEF  left ventricular
jection fraction; MR  mitral regurgitation on a 4-point scale (1 to 4); NQMI 
on–Q-wave myocardial infarction (MI); QMI  Q-wave MI; WMI  wall motion
ndex.egments with improvement in relative tracer concentration
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Viable Myocardium in Non–Q-Wave and Q-Wave MI February 18, 2004:592–8rom the stress to the resting images of 15% or greater.
ixed perfusion defect was determined when perfusion
efect was detected on both resting and 82Rb dipyridamole-
tress perfusion images in the same segments. Because
yocardial scar and hibernating myocardium might present
s fixed defects on the 82Rb dipyridamole perfusion images,
he resting 18FDG imaging was further performed to
ifferentiate scar (concordantly decreased 18FDG uptake in
he segments with perfusion defects on resting 82Rb perfu-
ion images) from hibernation (increased 18FDG uptake of
5% or more in the segments with perfusion defects on
esting 82Rb perfusion images). The left ventricle was
ivided into 24 segments (20) with four principal regions:
eptal, anterior, lateral, and inferior regions (Fig. 1). Be-
ause of significant variation and overlaps of coronary artery
lood supply, a scar detected by PET in two or more
rincipal regions were considered as multiregional infarc-
ion. For example, if scars were identified in the anterior,
nterior lateral, and lateral regions, we considered two
egional infarctions (PET criteria). If scars were identified
n anterior and anterior lateral regions, we considered them
s one region because only one principal region was involved
anterior region). Total IVM was defined as the reversal
efect segments (ischemia) plus mismatched defect seg-
ents (hibernation). The localizing sensitivity of the ECG
as given by the percentage of patients with PET scar in a
articular distribution who also had a pathologic Q-wave in
hat region; specificity was defined by the percentage of
atients without a scar in a distribution who did not have a
orresponding pathologic Q-wave there.
eft ventricular function. Left ventricular dimension, wall
otion, and LVEF were assessed using two-dimensional
chocardiography as routine clinical practice. Standard
arasternal long-, short-, four-, and two-chamber views
ere obtained. The left ventricle was divided into 16
egments as described by the American Society of Echocar-
iography (21), and segmental wall motion was scored as 1
igure 1. Illustration of the 24-segment model in the positron emission
omographic study. Left ventricle was divided into 24 segments with four
rincipal regions: septal (S), anterior (A), lateral (L), and inferior (I)
egions. Each principal region was sliced into basal, mid-, distal, and apical
ayers in the vertical and horizontal views. The segments between the
rincipal regions were anterior septum (as), anterior lateral (al), inferior
ateral (il), and inferior septum (is) as shown in the short-axis view. The
asal septum (horizontal axis) was not accounted as a myocardial segment
ecause of nonmyocardial membrane. Instead, the apical segment was
ccounted as the 24th segment.normal, 2  hypokinesis, 3  akinesis, 4  dyskinesis, 5 saneurysm. Wall motion index (WMI) was calculated as
he total scores divided by the number of segments.
tatistical analysis. Values are expressed as the mean 
D. Student unpaired t test was used to compare the means
f continuous variables for the two independent groups. The
hi-square testing was used to examine the difference in
iscrete variables. Linear regression analysis was used to
xplore the relationship between the number of Q waves on
CG and the number of scars on PET, and the relationship
etween LVEF and WMI. All values were expressed as
ean values  SD. A p value 0.05 was considered
tatistically significant.
ESULTS
linical characteristics. No significant differences in age,
ender, heart rate, history of coronary artery bypass grafting,
eft ventricular dimension and LVEF, severity of mitral
egurgitation, or mean wall motion index were noted
etween the NQMI and the QMI groups (Table 1, p 
.05). Multivessel coronary artery disease was more com-
on in the QMI group (72 % vs. 38 %, p  0.05) than the
QMI group in this study.
VM. Ischemic and hibernating myocardium were more
ommon in the patients with NQMI (91%) than QMI
61%, p  0.05). The segments with ischemia were 3.2 
.7 in the NQMI group and 1.7  2.6 in the QMI group
p  0.06). The segments with hibernation were 3.3  4.5
n the NQMI group and 1.2  1.7 in the QMI group (p 
.01). The total number of IVM (combination of ischemia
nd hibernation) was significantly higher in the NQMI
roup than in the QMI group (Fig. 2). The number of
egments with scar appeared to be more common in QMI
7.6  3.8) than in NQMI (6.5  4.2), but it did not reach
tatistical significance (p  0.33). Patients with a larger
mount of myocardium at high risk (3 segments with
VM) were twofold higher in the NQMI group than the
MI group (71% vs. 35%, p  0.01). Although LVEF
ended to be slightly lower in the QMI group than in the
QMI group (28  10 vs. 25  11%), it did not reach
tatistical significance (p  0.39). There were weak, but
igure 2. Comparison of ischemic viable myocardium and myocardial scar
etween the patients with non–Q-wave myocardial infarction (NQMI) and
hose with Q-wave myocardial infarction (QMI).ignificant, negative correlations between the number of scar
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February 18, 2004:592–8 Viable Myocardium in Non–Q-Wave and Q-Wave MIegments and the number of ischemic segments (r0.34,
 0.006) and hibernation segments (r  0.35, p 
.005) in the combined NQMI and QMI groups, suggest-
ng that patients with a larger amount of scar (a large
nfarction) had less IVM. There was no significant correla-
ion between the number of ischemic segments and the
umber of hibernation segments (r  0.08, p  0.52).
elationship between PET and ECG. Table 2 lists the
ensitivity and specificity of ECG Q-wave for the diagnosis
f MI in the different regions using PET image as a
eference standard in 43 patients with QMI. Anterior Q
aves had the highest specificity of the four regions.
lthough the diagnosis of lateral regional infarction by
CG Q-wave had high specificity (93%), the sensitivity
25%) was lower than the diagnosis of septal (67%, p 
.05), inferior (62%, p  0.05), and anterior (53%, p 
.06) regional infarctions. There was no significant relation-
hip between the number of Q waves and the number of the
car segments on PET (r  0.31, p  0.08) in the QMI
roup. However, a single regional infarction identified by
ET was more common in the NQMI group than the QMI
roup (62% vs. 28%, p  0.05), and multiple regional
nfarctions on PET were more common in the QMI group
han in the NQMI group (72% vs. 38%, p  0.05). Table 3
ists clinical and echocardiographic characteristics in the
atients with single and multiregional infarctions deter-
ined by PET. Patients with one regional infarction had
ewer Q waves, fewer diseased coronary vessels (p  0.01),
ower mean WMI (p 0.01), and higher LVEF (p 0.01)
han those with multiregional infarctions. Patients with one
egional infarction had more segments with IVM (p 
.01) and a fewer segments with myocardial scar (p 
.001) than those with multiregional infarctions.
rediction of IVM by echocardiography and ECG. In
he QMI group, the average number of Q waves was 4.2 
.0 in the patients with IVM and 4.7  2.2 in the patients
ithout IVM (p  0.05). As indicated in Table 4, there
ere no significant differences in the number of leads with
T segment elevation of 1 mm or with ST segment
epression of0.5 mm, in the sum of ST segment elevation
r depression in millimeter, LVEF, WMI, or left ventric-
lar dimension between the patients with and without IVM.
able 2. Sensitivity and Specificity of Q-Wave of ECG for
iagnosis of Myocardial Scars Identified by a Positron Emission
omography in Different Infarct Location in the QMI Group
n  43)
Infarct Location
Anterior Inferior Lateral Septal
ensitivity 53% 62% 25% 67%
pecificity 100% 53% 93% 54%
PV 100% 67% 67% 43%
PV 36% 47% 68% 75%
ccuracy 63% 58% 67% 58%
CG  electrocardiogram; NPV  negative predictive value; PPV  positive
redictive value; QMI  Q-wave myocardial infarction.here was no significant relationship between the number if Q waves and LVEF, or between the total number of
egments with IVM and LVEF. Wall motion indexes were
ignificantly correlated with the number of scar segments (r
0.54, p  0.001) and LVEF (r  0.67, p  0.001) in
he combined QMI and NQMI groups. There were no
ignificant correlations between WMI and the number of
schemic segments (r  0.25, p  0.05).
ISCUSSION
he prevalence of NQMI has increased over the past two
ecades. This may be related to more accurate identification
f MI by use of specific cardiac enzyme markers (troponin,
reatine kinase-MB). Early reperfusion with thrombolytic
herapy and acute percutaneous coronary artery intervention
ay reduce QMI and increase NQMI. However, a long-
erm prognosis of NQMI is not significantly different from
able 3. Comparison of a Signal Region With and Multiple
egional Infarctions (Scar) Identified by a Positron
mission Tomography
Single Region
(n  22)
Multiple Regions
(n  42)
umber of leads with Q waves 1.7  2.0* 3.5  2.8
R (beats/min) 74  13 82  19
AD vessels 2.2  0.8* 2.7  0.5
VDd (cm) 6.0  0.9 6.4  1.0
VDs (cm) 4.8  1.1 5.1  1.2
VEF (%) 33  11* 23  9
R severity 1.2  1.0 1.6  1.1
MI 1.8  0.5* 2.2  0.5
schemic segments 3.9  3.5* 1.4  2.3
ibernating segments 2.4  3.8 1.6  2.6
schemic viable segments 6.3  4.8* 2.9  3.2
car segments 4.1  2.4† 8.9  3.6
p  0.01; †p  0.001.
CAD vessels  number of epicardial coronary artery with 50% stenosis; HR 
eart rate; Ischemic viable segments  Ischemia  hibernation. LVDd  left
entricular end-diastolic diameter; LVDs  left ventricular end-systolic diameter;
VEF  left ventricular ejection fraction; MR  mitral regurgitation on a 4-point
cale; WMI  wall motion indexes by echocardiography.
able 4. Prediction of Ischemic Viable Myocardium by
chocardiography and Electrocardiography
Ischemic Viable
Myocardium
p Value
With
(n  49)
Without
(n  15)
umber of leads with ST 1 2.6  2.2 2.3  1.7 0.57
um of ST 1 (mm) 3.6  3.6 3.2  2.5 0.68
umber of leads with ST 2 2.1  2.2 1.4  1.9 0.26
um ST 2 (mm) 1.8  2.1 1.1  1.7 0.23
VDd (cm) 6.3  1.0 6.3  1.1 0.98
VDs (cm) 5.0  1.1 4.8  1.4 0.66
VEF (%) 27  11 25  10 0.54
R severity 1.5  1.1 1.5  1.1 1.00
MI 2.1  0.6 2.2  0.5 0.54
VDd left ventricular end-diastolic diameter; LVDs left ventricular end-systolic
iameter; LVEF  left ventricular ejection fraction; MR  mitral regurgitation on a
-point scale; ST 1  the number of ECG leads with ST elevation (1 mm);
T 2  number of ECG leads with ST depression (0.5 mm); Sum of ST 1 or
 the sum of ST elevation or depression on a 12-lead ECG; WMI wall motionndexes.
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Viable Myocardium in Non–Q-Wave and Q-Wave MI February 18, 2004:592–8hat of QMI. Because of frequent postinfarction cardiac
vents, the 1987 American College of Cardiology/American
eart Association Joint Task Force Report on Guidelines
or Coronary Arteriography recommended that NQMI was
he class I indication for coronary angiography (22).
Frequent cardiac events (postinfarction angina, MI) in
atients with NQMI strongly suggest that myocardium may
e at high risk due to incomplete reperfusion. Incompletely
erfused myocardium may manifest as stress-induced isch-
mia and/or hibernation (severe resting ischemia). The
urrent study confirms the clinical concern that patients
ith NQMI have more myocardium in jeopardy than
atients with QMI. Early studies with a small number of
atients reported that viable myocardium detected by PET
as more common in patients with NQMI than in those
ith QMI (23). Hashimoto and colleagues (24) reported
hat viable myocardium was observed in 10 (91%) of 11
atients with NQMI, but in only 4 (36%) of 11 patients
ith QMI. The present study not only showed that IVM
as more common in NQMI than in QMI (91% vs. 61%,
 0.05), but the amount of IVM was significantly greater
n NQMI than in QMI. Although one trial (15) did not
emonstrate clinical benefit of an invasive strategy with
arly coronary angiographically directed revascularization
fter NQMI, a recent study showed that patients who were
anaged with such an invasive strategy had less cardiac
vents (postinfarction angina and rehospitalization) than
hose managed conservatively (16). Our study shows a high
revalence of IVM in the patients with NQMI, further
upporting the use of the aggressive invasive approach.
When left ventricular dysfunction is present after MI,
ssessment of myocardial viability is critically important. In
atients with substantial myocardial viability, left ventricular
unction may significantly improve after revascularization.
atients with little viability preoperatively have a high rate
f early and late cardiac death and the need for heart
ransplantation after coronary bypass surgery as compared
ith patients with extensive viability (25,26). Patients with
iable myocardium had substantially better event-free sur-
ival with revascularization in comparison with medical
herapy (27,28). In this study, resting echocardiography and
lectrocardiography were not shown to be very useful for
dentifying IVM in patients with left ventricular dysfunction
n either QMI or NQMI. There was no significant corre-
ation between IVM and the number of ECG Q waves,
MI, or LVEF. However, WMI significantly correlated
ith scar segments and LVEF. The current study showed a
igh prevalence of IVM in patients with NQMI and left
entricular dysfunction. Patients with NQMI and one
egional infarction were most likely to have IVM in other
egions. This suggests that a complete assessment of myo-
ardial perfusion, residual myocardial ischemia, and hiber-
ation are necessary after NQMI, particularly in patients
ith left ventricular dysfunction. Early coronary angiogram
ith necessary revascularization may be considered in pa-ients with NQMI. Our study showed the sensitivity of oCG for detecting lateral infarction was poor. Routine
CG was neither sensitive nor specific for identification of
VM, which was consistent with the recent report that
T-segment elevation during stress test might indicate
yocardial scar rather than viable myocardium after MI
29).
In the current study, we combined resting and stress 82Rb
erfusion imaging with resting 18FDG imaging. The resting
nd stress 82Rb perfusion imaging identified ischemic myo-
ardium (reversible perfusion defect) through the detection
f reduced coronary artery flow. However, 82Rb perfusion
maging was unable to differentiate hibernating myocardium
rom myocardial scar in the segments with perfusion defects
n both resting and stress 82Rb perfusion images (fixed
efects); 18FDG metabolic PET imaging identified hiber-
ating myocardium in the segments with fixed defects. The
dvantage of the combination was to maximally identify
VM at high risk (both ischemia and hibernation). This is
articularly important in a patient with left ventricular
ysfunction because both stress-induced ischemia and hi-
ernating myocardium could exist in a patient, and IVM is
trongly associated with ischemic events (25,26,30). With-
ut this combination, one might have potentially missed
ither hibernating myocardium if resting, and stress 82Rb
erfusion imaging was performed only, or stressed-induced
schemia if resting 18FDG image was performed only.
Although PET used in this study is considered as a gold
tandard with a high sensitivity for the detection of hiber-
ating myocardium, it is relatively expensive, and not widely
vailable. A single photon emission computed tomography
ith resting thallium later redistribution or reinjection 18 to
4 h after an initial thallium injection has been shown to be
seful for identifying IVM (31–33). Further standardization
f the thallium redistribution technique and imaging pro-
ocol will enhance this technique. Exercise echocardiogra-
hy has been widely used for the detection of myocardial
schemia. It is less expensive, with sensitivity and specificity
pproximately equivalent to single photon emission com-
uted tomography. Dobutamine echocardiography has been
sed for the identification of IVM (34–36) with a high
pecificity for predicting recovery of systolic function after
evascularization, although the sensitivity for the detection
f myocardial viability is slightly lower than the nuclear
echniques (37,38). Both thallium redistribution imaging
nd dobutamine echocardiography can be used to identify
VM in QMI and NQMI. Recently, cardiac magnetic
esonance has been shown to be useful for identifying
yocardial viability (39).
tudy limitations. Previous coronary artery bypass grafting
ay alter blood supply to myocardium, and we did not have
etailed information regarding coronary collateral circula-
ion, making it difficult to determine culprit lesions in a few
atients. The number of the patients in this study is
elatively small, and we did not have long-term follow-up
ata. Therefore, we are unable to assess the prognostic value
f IVM in QMI and NQMI after revascularization. How-
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mportance of IVM for prognosis and beneficial effect of
oronary revascularization (19,25–28,34–36,40). In this
tudy, we did not have uniform cardiac enzyme data because
atients had old MI, and measurements of cardiac enzymes
ere performed in different laboratories with different
ormal references. Therefore, we are unable to determine a
elationship between cardiac enzymes and myocardial scar,
ibernation, and ischemia identified by PET.
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